ARS:年度报告
04/23 01:56
DEFA14A:其他
04/23 01:41
DEF 14A:股东委托书决议
04/23 01:16
Jasper Therapeutics | SC 13G:超过5%持股股东披露文件-Avidity Partners Management LP(5.1%),Avidity Partners Management (GP) LLC(5.1%)等
03/28 04:32
Jasper Therapeutics | 4:持股变动声明-高管 Mahal Jeetinder Singh
03/13 09:34
Jasper Therapeutics | 144:拟议出售证券
03/13 08:54
Jasper Therapeutics | 144:拟议出售证券
03/07 06:50
Jasper Therapeutics | S-8:员工福利计划证券登记
03/06 05:58
Jasper Therapeutics | 10-K:年度报表
03/06 05:04
Jasper Therapeutics | 8-K:重大事件
03/04 20:45
Jasper Therapeutics | 4:持股变动声明-高管 MARTELL RON
02/21 08:34
Jasper Therapeutics | 4:持股变动声明-高管 Mahal Jeetinder Singh
02/21 08:34
Jasper Therapeutics | 4:持股变动声明-高管 CROSS HERB
02/21 08:29
Jasper Therapeutics | 4:持股变动声明-高管 Tucker Edwin Jonathan
02/21 08:24
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Securities LLC(0.2%),Citadel Securities Group LP(0.2%)等
02/15 07:24
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Qiming U.S. Healthcare Fund II, L.P.(6.2%),Qiming U.S. Healthcare GP II, LLC(6.2%)等
02/15 06:41
Jasper Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等
02/14 22:42
Jasper Therapeutics | 4:持股变动声明- Carlyle Group Inc.
02/13 07:25
Jasper Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-The Carlyle Group Inc.(7.1%),Carlyle Holdings I GP Inc.(7.1%)等
02/13 07:05
Jasper Therapeutics | 4:持股变动声明-股东 Velan Capital Investment Management LP
02/10 09:45
暂无数据
暂无数据